AJ Vaccines A/S: Financial statements 2019
CVR: 37911143
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
AJ Vaccines A/S (CVR 37911143) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 323,471,000 and a net result of DKK -288,603,000 compared with DKK -244,490,000 the year before. That is a decrease of 10.7% compared with the year before. The profit margin was -89.2%. Equity in the 2019 report amounted to DKK 1,185,744,000. The solvency ratio was 64.1%. The company had 719 employees in the financial year.
- Revenue
- DKK 323,471,000
- Gross Profit
- DKK -224,533,000
- Profit/Loss
- DKK -288,603,000
- Equity
- DKK 1,185,744,000
- Total Assets
- DKK 1,850,926,000
- Employees
- 719
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 323.5M | -224.5M | -288.6M | 1.2B | 719 |
| 2018 | 362.2M | -150.7M | -244.5M | 903.2M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of July 31, 2019, Jerome Christian Roger Cabannes is registered as director of AJ Vaccines A/S.
As of July 31, 2019, Jérome Christian Roger Cabannes is registered as director of AJ Vaccines A/S.
AJ Vaccines A/S has published its annual report for 2018. Revenue came to DKK 362,192,000, and the net result was DKK -244,490,000.
About AJ Vaccines A/S
AJ Vaccines A/S is a Danish company of the type Aktieselskab based in København S, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Aktieselskabet af august 2016. The management consists of Ole Vahlgren. The board consists of Abdulaziz Abdulhamid Abdulrhman Albassam (chair), Mohammed Ali A Alesayi, Mustafa Nasir Farooki and Saddam Abdulqawi Hussein Alhumaikani. The company is owned by AJ Vaccines Holding ApS. The company has 499 employees (2026). In 2025, the company reported revenue of DKK 389,681,000 and a net result of DKK -483,351,000 compared with DKK -807,117,000 the year before. Equity in the 2025 report amounted to DKK 288,465,000.
